ProductsPricingResearchSupportPartner

₹ 14960 / 110 shares

IPO Details

RHP/DRHP

Issue Date

03 Jun - 5 Jun'24

Investment/lot

₹ 14960

Price Range

129 - 136

Lot Size

110

IPO Size

₹ 130.15 Cr

IPO Listing Details

Listing On

10 Jun'24

Issue Price

136

Listed Price

₹ ₹164.95

Retail Gain/Listing Gain

21.29%

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

WATCH AND LEARN
All you need to know about Kronox Lab Sciences Limited IPO
Explore Kronox Lab Sciences IPO, a manufacturer of high-purity specialty fine chemicals for diverse industries, offering over 185 products globally. Learn about their robust manufacturing facilities, extensive customer base, and ongoing research and development efforts in this video.

Kronox Lab Sciences manufactures high-purity speciality fine chemicals for diverse industries. These chemicals are used as reacting agents and raw materials for APIs, excipients in pharmaceuticals, scientific reagents, nutraceutical ingredients, biotech intermediates, agrochemical ingredients, personal care ingredients, refining agents in metal refineries, and animal health products.

With that, let's take a look at the competitive strength and risk factors for Kronox Lab Sciences Limited:

Wide range of products finding applications in diversified end-user industries

The company’s products can be used across various industries like pharmaceuticals, scientific and laboratory research, nutraceuticals, biotech, agrochemicals, personal care, metallurgy and animal health. Over the years, the company has expanded their product portfolio to more than 185 products.

High entry and exit barriers

The company’s manufacturing process involves multi-step production and purification to produce fine chemicals. Given the nature of their applications, their processes and products adhere to established domestic and international standards and stringent customer specifications. As part of the detailed approval process by potential customers or their agencies/consultants, they must submit extensive documentation about their manufacturing facilities and other details, including processes, quality control measures, certifications, product specifications, quality standards, and regulatory compliances.

Zero debt company with strong and consistent financial performance

The company has experienced sustained growth in various financial indicators, including revenue and PAT, as well as consistent improvement in their balance sheet over the last three fiscals, with an increase in net worth. Their robust balance sheet, positive operating cash flows, and zero debt position enable them to fund strategic initiatives, pursue growth opportunities, and better manage unanticipated cash flow variations. Their financial strength provides a valuable competitive advantage, particularly with access to financing, which is critical to their business.
  • Their products must meet domestic and international industry standards. Any deviation could lead to customer rejection and harm the company's reputation.

  • If they fail to execute their strategy to expand their business or production capacity, their business and prospects may be materially and adversely affected.

  • Their products are supplied in limited quantities for specific industries. Any demand reduction could result in loss of business and negatively impact their financial performance and condition.

Key Strategies

  • Expand the product portfolio, increasing the supply of products to existing customers and tapping new customers in existing and new geographies.

  • Expand the capacity for existing products and diversify into new products by setting up a new manufacturing facility.

  • Explore newer applications for existing products and develop new products that are in synergy with current and future operations.

Here are the key financials for Kronox Lab Sciences Limited:

Particulars (in Rs. million)

Particulars (in Rs. million)

WHAT ARE YOU LOOKING FOR?
Applying for an IPO for the first time?
Here's a video playlist to help you invest in the upcoming Kronox Lab Sciences Limited IPO
How to apply for IPO through ASBA

How to apply for IPO through ASBA

Kotak Securities

04m 01s

Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO.

Here are the steps to apply for Kronox Lab Sciences Ltd IPO:

Step 1: Log in to your Kotak Securities Demat account Log in to your Demat account to access IPO investments. Next, select the current IPO section.

Step 2: Specify IPO details Enter the number of lots and the price you wish to apply for.

Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.

Step 4: Mandate Notification Your UPI app will receive a mandate notification to block funds.

Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.

Kronox Lab Sciences IPO FAQs

Kronox Lab Sciences IPO will list on 2024-06-10.

130.15 is the issue size of Kronox Lab Sciences IPO.

The minimum lot size is 110 shares and the investment required is ₹14960.

The price band of Kronox Lab Sciences IPO is ₹129 to ₹136.

You can read more about Kronox Lab Sciences and its IPO from the company’s red herring prospectus (RHP) here.

The Kronox Lab Sciences Limited IPO has an issue size of Rs. 130.15 crores. The IPO opens for subscription on 3rd June 2024 and closes on 5th June 2024

KFin Technologies Limited is the registrar for this IPO.

Open Demat Account to Invest in any IPO
+91 -

personImage
Open Demat Account to Invest in any IPO
+91 -